The scientist’s investigation covers issues in Biochemistry, Peptide, Peptide sequence, Cecropin and Virus. His Biochemistry research incorporates themes from Molecular biology and Bacteria. His work deals with themes such as Amino acid and Biological activity, which intersect with Peptide.
His Peptide sequence research includes themes of Antimicrobial peptides and Peptide synthesis. His work carried out in the field of Cecropin brings together such families of science as Protein primary structure, Antibacterial agent, Stereochemistry and Membrane permeability. Within one scientific family, David Andreu focuses on topics pertaining to Antigen under Virus, and may sometimes address concerns connected to Arg-Gly-Asp.
His primary areas of study are Peptide, Biochemistry, Epitope, Stereochemistry and Internal medicine. His Peptide study integrates concerns from other disciplines, such as Amino acid, Peptide sequence and Membrane. His Cecropin and Cell-penetrating peptide study are his primary interests in Biochemistry.
His study in Epitope is interdisciplinary in nature, drawing from both Molecular biology, Immunogenicity and Virology. His Internal medicine study typically links adjacent topics like Cardiology. Many of his research projects under Cardiology are closely connected to In patient with In patient, tying the diverse disciplines of science together.
His primary scientific interests are in Peptide, Internal medicine, Cardiology, Ablation and Biochemistry. The study incorporates disciplines such as Biophysics, Peptide sequence, In vitro and Virology in addition to Peptide. In Virology, David Andreu works on issues like Immunogenicity, which are connected to Epitope and Foot-and-mouth disease virus.
His research in the fields of Ejection fraction, Myocardial infarction, Ventricular tachycardia ablation and Implantable cardioverter-defibrillator overlaps with other disciplines such as In patient. The Cardiology study combines topics in areas such as Long term outcomes and First line. His studies in Ablation integrate themes in fields like Ventricular tachycardia, Magnetic resonance imaging, Cardiac magnetic resonance and Atrial fibrillation.
His primary areas of investigation include Internal medicine, Cardiology, Ablation, Ventricular tachycardia and Catheter ablation. In general Internal medicine study, his work on Ejection fraction, Myocardial infarction and Cardiac imaging often relates to the realm of Cardiac skeleton and Three dimensional printing, thereby connecting several areas of interest. His work on Ventricular outflow tract, Coronary sinus and Pulmonary valve as part of general Cardiology research is frequently linked to Site location and Left coronary cusp, thereby connecting diverse disciplines of science.
He has included themes like Implantable cardioverter-defibrillator, Magnetic resonance imaging and Nuclear medicine in his Ablation study. David Andreu interconnects Substrate mapping, Cardiomyopathy, Long term outcomes and Fluoroscopy in the investigation of issues within Ventricular tachycardia. His Catheter ablation research includes elements of Odds ratio, Surgery and Site of origin.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
All-D amino acid-containing channel-forming antibiotic peptides.
David Wade;Anita Boman;Birgitta Wahlin;C. M. Drain.
Proceedings of the National Academy of Sciences of the United States of America (1990)
Animal antimicrobial peptides: an overview.
David Andreu;Luis Rivas.
Binding and action of cecropin and cecropin analogues: antibacterial peptides from insects.
Håkan Steiner;David Andreu;R.B. Merrifield.
Biochimica et Biophysica Acta (1988)
Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.
David Andreu;Josep Ubach;Anita Boman;Birgitta Wåhlin.
FEBS Letters (1992)
A receptor for the enantioselective recognition of phenylalanine and tryptophan under neutral conditions
Amalia Galan;David Andreu;Antonio M. Echavarren;Pilar Prados.
Journal of the American Chemical Society (1992)
A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants.
O Taboga;C Tami;E Carrillo;J I Núñez.
Journal of Virology (1997)
N-terminal analogues of cecropin A: synthesis, antibacterial activity, and conformational properties.
David Andreu;R. B. Merrifield;Haakan Steiner;Hans G. Boman.
A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C.
M. G. Mateu;M. A. Martínez;L. Capucci;D. Andreu.
Journal of General Virology (1990)
Cell Recognition by Foot-and-Mouth Disease Virus That Lacks the RGD Integrin-Binding Motif: Flexibility in Aphthovirus Receptor Usage
Eric Baranowski;Carmen M. Ruiz-Jarabo;Noemi Sevilla;David Andreu.
Journal of Virology (2000)
Structure of the major antigenic loop of foot-and-mouth disease virus complexed with a neutralizing antibody: direct involvement of the Arg-Gly-Asp motif in the interaction.
N. Verdaguer;M.G. Mateu;D. Andreu;E. Giralt.
The EMBO Journal (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: